stockrowResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Return on invested capital
ResMed Inc.'s return on invested capital over the twelve months to 30 September 2026 was 22.8%, up 1.4 percentage points from fiscal 2026 (21.4%). Over the past ten years it has ranged from 11.4% (fiscal 2019) to 21.9% (fiscal 2015); the current reading is higher than 92% of that period. That is above the Medical Instruments & Supplies industry median of 0.13% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | 21.4% | 1.93 |
| FY2025 | 19.5% | 3.95 |
| FY2024 | 15.5% | 2.24 |
| FY2023 | 13.3% | (2.97) |
| FY2022 | 16.2% | (1.24) |
| FY2021 | 17.5% | 1.65 |
| FY2020 | 15.8% | 4.45 |
| FY2019 | 11.4% | (4.45) |
| FY2018 | 15.8% | 3.82 |
| FY2017 | 12.0% | (2.60) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| RMD ResMed Inc. | 22.8% |
| WST West Pharmaceutical Services, Inc. compare | 18.0% |
| MDLN Medline Inc. compare | 17.8% |
| ALGN Align Technology, Inc. compare | 12.3% |
| BDX Becton, Dickinson and Company compare | 3.89% |
| COO The Cooper Companies, Inc. compare | 3.17% |
| ALC Alcon compare | 2.38% |
| SOLV Solventum Corporation compare | 0.00% |
| BAX Baxter International Inc. compare | −1.05% |
| Medical Instruments & Supplies industry median | 0.13% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement